5 Biotechs Awaiting FDA Decisions in January 2018 Post author:Sam Post published:December 27, 2017 Post category:BioPharma From 1997 through 2013, there was an average of 27 novel drugs approved in the U.S. per year. Source: BioSpace You Might Also Like On a Roll: FDA OKs Genentech's Gazyva for Untreated Follicular Lymphoma November 16, 2017 Zymeworks Presents Safety And Anti-Tumor Activity Data From The Ongoing Phase I Study Of ZW25 At ASCO Annual Meeting (ASCO 2017) June 4, 2017 ICON Reports Fourth Quarter And Full Year 2016 Results February 15, 2017
Zymeworks Presents Safety And Anti-Tumor Activity Data From The Ongoing Phase I Study Of ZW25 At ASCO Annual Meeting (ASCO 2017) June 4, 2017